• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $TLRY

    Tilray Brands Inc.

    Subscribe to $TLRY
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Tilray, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products. The company operates through five segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, Wellness Business, and Business Under Development. It provides medical and adult-use cannabis products; pharmaceutical and wellness products; beverage alcohol products; and hemp-based food and other wellness products. The company offers its products to retailers, wholesalers, patients, physicians, pharmacies, clinics, hospitals, governments, and researchers. It has operations in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company was formerly known as Aphria Inc. Tilray, Inc. was incorporated in 2018 and is based in New York, New York.

    IPO Year: 2018

    Exchange: NASDAQ

    Website: tilray.com

    Recent Analyst Ratings for Tilray Brands Inc.

    DatePrice TargetRatingAnalyst
    4/5/2024$2.25 → $2.75Neutral
    Alliance Global Partners
    11/2/2022$3.90Mkt Perform
    Bernstein
    7/29/2022$3.00Hold → Sell
    The Benchmark Company
    3/4/2022$9.00Hold → Buy
    Canaccord Genuity
    1/11/2022$7.40 → $6.90Neutral
    Cantor Fitzgerald
    1/7/2022$11.80 → $7.40Neutral
    Cantor Fitzgerald
    11/18/2021$10.00Underweight
    Barclays
    11/1/2021$18.00 → $11.80Overweight → Neutral
    Cantor Fitzgerald
    10/8/2021$14.00 → $12.00Neutral
    CIBC
    9/17/2021$19.00 → $18.00Overweight
    Cantor Fitzgerald
    See more ratings

    Tilray Brands Inc. Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President and CEO Simon Irwin D exercised 706,216 shares at a strike of $0.58 and covered exercise/tax liability with 374,295 shares, increasing direct ownership by 7% to 4,826,493 units (SEC Form 4)

    4 - Tilray Brands, Inc. (0001731348) (Issuer)

    8/4/25 4:07:08 PM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Chief Financial Officer Merton Carl A exercised 93,928 shares at a strike of $0.58 and covered exercise/tax liability with 49,782 shares, increasing direct ownership by 5% to 920,497 units (SEC Form 4)

    4 - Tilray Brands, Inc. (0001731348) (Issuer)

    8/4/25 4:06:42 PM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Global General Counsel Gendel Mitchell exercised 93,928 shares at a strike of $0.58, covered exercise/tax liability with 49,782 shares and bought $3,496 worth of shares (6,000 units at $0.58), increasing direct ownership by 8% to 698,287 units (SEC Form 4)

    4 - Tilray Brands, Inc. (0001731348) (Issuer)

    8/4/25 4:06:19 PM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Chief Strategy Officer Faltischek Denise M exercised 93,928 shares at a strike of $0.58 and covered exercise/tax liability with 49,782 shares, increasing direct ownership by 6% to 824,782 units (SEC Form 4)

    4 - Tilray Brands, Inc. (0001731348) (Issuer)

    8/4/25 4:05:55 PM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Chief Strategy Officer Faltischek Denise M exercised 261,194 shares at a strike of $0.61 and covered exercise/tax liability with 138,433 shares, increasing direct ownership by 19% to 780,636 units (SEC Form 4)

    4 - Tilray Brands, Inc. (0001731348) (Issuer)

    7/31/25 6:26:10 PM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 4 filed by Director Cohen Steven Michael

    4 - Tilray Brands, Inc. (0001731348) (Issuer)

    7/31/25 6:22:43 PM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Director Herhalt Johann Michael exercised 124,378 shares at a strike of $0.61 and covered exercise/tax liability with 65,921 shares, increasing direct ownership by 51% to 174,009 units (SEC Form 4)

    4 - Tilray Brands, Inc. (0001731348) (Issuer)

    7/31/25 6:21:36 PM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Director Looney Thomas P. exercised 124,378 shares at a strike of $0.61, increasing direct ownership by 54% to 354,416 units (SEC Form 4)

    4 - Tilray Brands, Inc. (0001731348) (Issuer)

    7/31/25 6:21:09 PM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Director Hopkinson David G. exercised 124,378 shares at a strike of $0.61, increasing direct ownership by 59% to 335,563 units (SEC Form 4)

    4 - Tilray Brands, Inc. (0001731348) (Issuer)

    7/31/25 6:20:35 PM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Director Clanachan David F exercised 124,378 shares at a strike of $0.61 and covered exercise/tax liability with 65,921 shares, increasing direct ownership by 52% to 170,959 units (SEC Form 4)

    4 - Tilray Brands, Inc. (0001731348) (Issuer)

    7/31/25 6:20:01 PM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Tilray Brands Inc. Press Releases

    Fastest customizable press release news feed in the world

    View All

    Tilray Brands Reconfirms Strategy to Regain Nasdaq Compliance; Requests Extension to Meet Listing Requirements

    NEW YORK and LEAMINGTON, Ontario, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (NASDAQ:TLRY, TSX:TLRY), a global lifestyle consumer packaged goods company at the forefront of the cannabis, beverage, and wellness industries, today announced that the Company has submitted an application requesting an extension to regain compliance with Nasdaq's listing standards regarding its price per share. The Company is evaluating several options including, but not limited to, a stockholder-approved Reverse Stock Split to address capital structure and maintain adherence to Nasdaq's continued listing requirements. Irwin Simon, Chief Executive Officer, Tilray Brands,

    8/14/25 7:00:00 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Tilray Medical Forms Strategic Partnership in Italy to Broaden Access to Medical Cannabis Extracts

    NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. ("Tilray") (NASDAQ:TLRY, TSX:TLRY) and a global leader in medical cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, announced today that its wholly-owned subsidiary, FL Group S.R.L., has entered into a strategic partnership with L. Molteni & C. dei F.lli Alitti Società di Esercizio S.p.A. ("Molteni"), an Italian pharmaceutical firm specializing in pain therapies and substance dependence. The partnership is designed to broaden the availability of Tilray Medical cannabis extracts for patients across Italy. M

    8/13/25 7:00:00 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Tilray Expands Hemp-Derived Delta-9 THC Beverage Lineup with 10mg Drinks from Fizzy Jane's and Happy Flower Brands

    NEW YORK, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray") (NASDAQ:TLRY, TSX:TLRY) is building on the momentum of its hemp-derived Delta-9 THC (HDD9) beverage portfolio with new 10mg format extensions from its brands: Fizzy Jane's and Happy Flower. Fizzy Jane's, the sparkling seltzer line that debuted this spring in Georgia, North Carolina, and South Carolina, is now available in a 10mg HDD9 THC format, enhancing the buzz while keeping the same crisp, fruit-forward refreshment fans love. With 15 calories or fewer per can, Fizzy Jane's seltzers come in three vibrant flavors: Vanilla, Blood Orange, and Lemon Lime. The new 10mg drinks join the original 5mg lineup and are now

    8/12/25 7:00:00 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Tilray Brands Launches The Humble Seed Whole Wheat Protein Crackers at Whole Foods Market

    NEW YORK and WINNIPEG, Manitoba, Aug. 07, 2025 (GLOBE NEWSWIRE) -- The Humble Seed, a better-for-you snack brand from Tilray Wellness a subsidiary of Tilray Brands, Inc. ("Tilray") (NASDAQ:TLRY, TSX:TLRY), today announced the launch of its new Whole Wheat Protein Crackers, featuring 5g of plant-based protein per serving. Available in three crave-worthy flavors—Sea Salt, Garlic Herb, and Rosemary Sea Salt—this innovation is now debuting exclusively at select Whole Foods Market stores nationwide. The Humble Seed makes wholesome superseeds the star of the show. The brand's new Whole Wheat Protein Crackers combine a blend of hemp, chia, flax, pumpkin, sesame, and sunflower seeds with whole wh

    8/7/25 7:00:00 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Tilray Brands Reports Fourth Quarter and Fiscal 2025 Financial Results

    Fiscal Year Net Revenue of $821 Million, $834 Million in Constant Currency, Strategic Decisions Impacted Revenue by $35 Million Q4 Consolidated Adjusted EBITDA is the 2nd Highest in the Company's History International Cannabis Revenue Increased 71% in Q4 and 19% for the Fiscal Year; Canadian Cannabis Remained #1 by Revenue in the Fiscal Year; Global Cannabis Gross Margin Increased by ~700 Basis Points in the Fiscal Year 19% Revenue Growth in Tilray Beverages with $241 Million for the Fiscal Year 9% Revenue Growth in Tilray Wellness with $60 Million for the Fiscal Year Strong Balance Sheet with $256 Million Available in Cash and Marketable Securities; Total Debt Repayments of ~$100 Milli

    7/28/25 4:30:13 PM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Award-Winning Breckenridge Distillery Makes Bold Entry into Tequila with Launch of Casa Breck

    BRECKENRIDGE, Colo., July 24, 2025 (GLOBE NEWSWIRE) -- Breckenridge Distillery, an award-winning craft distillery and spirits brand by Tilray Brands, Inc. (NASDAQ:TLRY, TSX:TLRY), proudly celebrates International Tequila Day with the launch of Casa Breck Tequila - a bold leap into a new spirits category. Crafted with reverence for tradition and inspired by cross-cultural storytelling, Casa Breck represents a striking fusion of the Rocky Mountains' rugged spirit and the vibrant heart of Jalisco, Mexico. Photo Courtesy: Breckenridge Distillery Casa Breck Blanco and Casa Breck Reposado are the first offerings in this new line, each one a tribute to the time-honored craftsmanship of

    7/24/25 7:00:00 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Breckenridge Distillery Launches Mock One: Bold, Premium Non-Alcoholic Alternatives to Whiskey, Tequila, Gin & Rum - Crafted for Everyone Who Loves a Great Drink

    BRECKENRIDGE, Colo., July 17, 2025 (GLOBE NEWSWIRE) -- Breckenridge Distillery, an award-winning craft distillery and spirits brand by Tilray Brands, Inc. (NASDAQ:TLRY, TSX:TLRY), is pleased to announce the launch of Mock One, a new line of non-alcoholic spirits. Mock One is not just another non-alcoholic spirit - it's crafted by the team behind one of the most awarded craft distilleries in the United States. Backed by the expertise of the renowned Breckenridge Distillery, recipient of nine Icons of Whisky awards for excellence in quality, innovation, branding, and taste, Mock One brings the same uncompromising standards to the zero-proof category with spirit alternatives inspired by their

    7/17/25 7:00:00 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Tilray Brands to Announce Fourth Quarter and Fiscal Year 2025 Financial Results on July 28, 2025

    NEW YORK and LEAMINGTON, Ontario, July 09, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (NASDAQ:TLRY, TSX:TLRY), a global lifestyle and consumer packaged goods company at the forefront of the beverage, cannabis and wellness industries, today announced that the Company will release its financial results for the fourth quarter and full fiscal year ended May 31, 2025, after market close on Monday, July 28, 2025. Live Conference Call and Audio Webcast Tilray will host a live conference call, which will be webcast, to discuss these results at 4:30 PM Eastern Time. The webcast can be accessed on the Events & Presentations section of Tilray's Investor Relations websi

    7/9/25 7:00:00 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Beers, Live Music, Hot Dogs and Fireworks: Everything You Need for an Epic 4th Of July Celebration

    NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray") (NASDAQ:TLRY, TSX:TLRY), a global lifestyle and consumer packaged goods company, is excited to share that its craft beer taprooms across the U.S. are rolling out a stellar lineup of events to make this 4th of July unforgettable. From live music and limited-release brews to barbecues and Independence Day festivities, each taproom is set to bring its own unique flair to the holiday. 10 Barrel Brewing 10 Barrel, East Bend, OR - Over the top 4th of July food, cocktail and crowler specials. Best-dressed patriotic contest and fireworks in the parking lot. All activations are free and open to all ages.10 Barrel, West Bend

    7/1/25 8:00:00 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Breckenridge Distillery Unveils Limited-Edition Collectors Art Series Collaboration with Renowned Artist Miles Toland

    BRECKENRIDGE, Colo., July 01, 2025 (GLOBE NEWSWIRE) -- Breckenridge Distillery, one of the most-awarded craft distilleries in the U.S., and a craft spirits brand by Tilray Brands, Inc. (NASDAQ:TLRY, TSX:TLRY), proudly announces the fifth edition of its acclaimed Collectors Art Series. This year, the distillery partnered with muralist and painter Miles Toland to create a breathtaking label and mural as part of its limited release, the Breckenridge Calvados Cask Finish. Born in Santa Fe, New Mexico, and currently based in Spokane, Washington, Toland is known for his immersive murals and studio work that explore the liminal realms between sleep and wakefulness. His art blends geometric pat

    7/1/25 7:00:00 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Tilray Brands Inc. SEC Filings

    View All

    SEC Form 10-K filed by Tilray Brands Inc.

    10-K - Tilray Brands, Inc. (0001731348) (Filer)

    7/28/25 7:22:54 PM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Tilray Brands Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Tilray Brands, Inc. (0001731348) (Filer)

    7/28/25 4:32:41 PM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Tilray Brands Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities

    8-K - Tilray Brands, Inc. (0001731348) (Filer)

    6/23/25 4:10:42 PM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Tilray Brands Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - Tilray Brands, Inc. (0001731348) (Filer)

    6/10/25 5:00:39 PM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form DEFA14A filed by Tilray Brands Inc.

    DEFA14A - Tilray Brands, Inc. (0001731348) (Filer)

    4/28/25 4:55:34 PM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form DEF 14A filed by Tilray Brands Inc.

    DEF 14A - Tilray Brands, Inc. (0001731348) (Filer)

    4/28/25 4:53:44 PM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Tilray Brands Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities

    8-K - Tilray Brands, Inc. (0001731348) (Filer)

    4/25/25 4:06:00 PM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form PRE 14A filed by Tilray Brands Inc.

    PRE 14A - Tilray Brands, Inc. (0001731348) (Filer)

    4/17/25 8:32:23 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Tilray Brands Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Tilray Brands, Inc. (0001731348) (Filer)

    4/17/25 7:42:47 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 10-Q filed by Tilray Brands Inc.

    10-Q - Tilray Brands, Inc. (0001731348) (Filer)

    4/8/25 5:01:26 PM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Tilray Brands Inc. Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Alliance Global Partners reiterated coverage on Tilray with a new price target

    Alliance Global Partners reiterated coverage of Tilray with a rating of Neutral and set a new price target of $2.75 from $2.25 previously

    4/5/24 7:39:50 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Bernstein initiated coverage on Tilray with a new price target

    Bernstein initiated coverage of Tilray with a rating of Mkt Perform and set a new price target of $3.90

    11/2/22 6:37:00 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Tilray downgraded by The Benchmark Company with a new price target

    The Benchmark Company downgraded Tilray from Hold to Sell and set a new price target of $3.00

    7/29/22 7:19:40 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Tilray upgraded by Canaccord Genuity with a new price target

    Canaccord Genuity upgraded Tilray from Hold to Buy and set a new price target of $9.00

    3/4/22 6:10:38 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Cantor Fitzgerald reiterated coverage on Tilray with a new price target

    Cantor Fitzgerald reiterated coverage of Tilray with a rating of Neutral and set a new price target of $6.90 from $7.40 previously

    1/11/22 4:39:43 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Cantor Fitzgerald reiterated coverage on Tilray with a new price target

    Cantor Fitzgerald reiterated coverage of Tilray with a rating of Neutral and set a new price target of $7.40 from $11.80 previously

    1/7/22 4:42:16 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Barclays initiated coverage on Tilray with a new price target

    Barclays initiated coverage of Tilray with a rating of Underweight and set a new price target of $10.00

    11/18/21 5:10:04 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Tilray downgraded by Cantor Fitzgerald with a new price target

    Cantor Fitzgerald downgraded Tilray from Overweight to Neutral and set a new price target of $11.80 from $18.00 previously

    11/1/21 7:50:22 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    CIBC reiterated coverage on Tilray with a new price target

    CIBC reiterated coverage of Tilray with a rating of Neutral and set a new price target of $12.00 from $14.00 previously

    10/8/21 7:28:21 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Cantor Fitzgerald reiterated coverage on Tilray with a new price target

    Cantor Fitzgerald reiterated coverage of Tilray with a rating of Overweight and set a new price target of $18.00 from $19.00 previously

    9/17/21 4:45:40 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Tilray Brands Inc. Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Global General Counsel Gendel Mitchell exercised 93,928 shares at a strike of $0.58, covered exercise/tax liability with 49,782 shares and bought $3,496 worth of shares (6,000 units at $0.58), increasing direct ownership by 8% to 698,287 units (SEC Form 4)

    4 - Tilray Brands, Inc. (0001731348) (Issuer)

    8/4/25 4:06:19 PM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    President and CEO Simon Irwin D bought $100,106 worth of shares (165,000 units at $0.61), increasing direct ownership by 4% to 3,941,633 units (SEC Form 4)

    4 - Tilray Brands, Inc. (0001731348) (Issuer)

    7/30/25 6:52:32 PM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Chief Financial Officer Merton Carl A bought $19,939 worth of shares (33,500 units at $0.60), increasing direct ownership by 4% to 798,069 units (SEC Form 4)

    4 - Tilray Brands, Inc. (0001731348) (Issuer)

    7/30/25 3:12:46 PM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Chief Financial Officer Merton Carl A bought $35,360 worth of shares (26,000 units at $1.36) (SEC Form 4)

    4 - Tilray Brands, Inc. (0001731348) (Issuer)

    11/18/24 11:29:05 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Faltischek Denise M bought $20,500 worth of shares (10,000 units at $2.05), increasing direct ownership by 4% to 293,269 units (SEC Form 4)

    4 - Tilray Brands, Inc. (0001731348) (Issuer)

    1/18/24 8:32:10 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Gendel Mitchell bought $14,256 worth of shares (7,200 units at $1.98), increasing direct ownership by 4% to 195,796 units (SEC Form 4)

    4 - Tilray Brands, Inc. (0001731348) (Issuer)

    1/16/24 1:07:47 PM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Gendel Mitchell bought $10,098 worth of shares (5,400 units at $1.87), increasing direct ownership by 3% to 188,596 units (SEC Form 4)

    4 - Tilray Brands, Inc. (0001731348) (Issuer)

    1/12/24 3:39:01 PM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Simon Irwin D bought $100,956 worth of shares (53,700 units at $1.88), increasing direct ownership by 3% to 2,033,058 units (SEC Form 4)

    4 - Tilray Brands, Inc. (0001731348) (Issuer)

    1/12/24 3:36:49 PM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Merton Carl A bought $37,400 worth of shares (20,000 units at $1.87) (SEC Form 4)

    4 - Tilray Brands, Inc. (0001731348) (Issuer)

    1/12/24 3:36:08 PM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Tilray Brands Inc. Financials

    Live finance-specific insights

    View All

    Tilray Brands Reports Fourth Quarter and Fiscal 2025 Financial Results

    Fiscal Year Net Revenue of $821 Million, $834 Million in Constant Currency, Strategic Decisions Impacted Revenue by $35 Million Q4 Consolidated Adjusted EBITDA is the 2nd Highest in the Company's History International Cannabis Revenue Increased 71% in Q4 and 19% for the Fiscal Year; Canadian Cannabis Remained #1 by Revenue in the Fiscal Year; Global Cannabis Gross Margin Increased by ~700 Basis Points in the Fiscal Year 19% Revenue Growth in Tilray Beverages with $241 Million for the Fiscal Year 9% Revenue Growth in Tilray Wellness with $60 Million for the Fiscal Year Strong Balance Sheet with $256 Million Available in Cash and Marketable Securities; Total Debt Repayments of ~$100 Milli

    7/28/25 4:30:13 PM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Tilray Brands to Announce Fourth Quarter and Fiscal Year 2025 Financial Results on July 28, 2025

    NEW YORK and LEAMINGTON, Ontario, July 09, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (NASDAQ:TLRY, TSX:TLRY), a global lifestyle and consumer packaged goods company at the forefront of the beverage, cannabis and wellness industries, today announced that the Company will release its financial results for the fourth quarter and full fiscal year ended May 31, 2025, after market close on Monday, July 28, 2025. Live Conference Call and Audio Webcast Tilray will host a live conference call, which will be webcast, to discuss these results at 4:30 PM Eastern Time. The webcast can be accessed on the Events & Presentations section of Tilray's Investor Relations websi

    7/9/25 7:00:00 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Tilray Brands Reports Q3 Fiscal 2025 Financial Results

    Tilray Confirms No Current Impact of Tariffs Generated Net Revenue of $186 Million in the Third Quarter, $193 Million in Constant Currency; Strategic Initiatives and SKU Rationalization Impacted Revenue by $13 Million Tilray Beverage Expands U.S. Distribution of Hemp-Derived THC Drinks Across 10 States, Increases Project 420 Cost Savings Plan to $33 Million Tilray Cannabis Increased Gross Margins by 800 bps, Remains the Leader in Canada by Sales Performance, and Generates Strong Sales Growth in Germany Strengthens Balance Sheet with Convertible Note Reduction of $58 Million and Total Debt Reduction of $71 Million, $248 Million Available in Cash and Marketable Securities NEW Y

    4/8/25 7:00:00 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Tilray Brands, Inc. to Announce Third Quarter Fiscal 2025 Financial Results on April 8, 2025

    NEW YORK and LEAMINGTON, Ontario, March 27, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (NASDAQ:TLRY, TSX:TLRY), a global lifestyle and consumer packaged goods company at the forefront of beverage, cannabis and wellness industries, today announced that the Company will release financial results for its third quarter fiscal 2025 ended February 28, 2025 before financial markets open on April 8, 2025. Live Conference Call and Audio Webcast Tilray will hold a live conference call, which will be webcast, to discuss these results at 8:30 a.m. Eastern Time. The webcast can be accessed in the Investors section of Tilray's website at www.Tilray.com. About Tilray Bran

    3/27/25 4:30:00 PM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Tilray Brands Reports Q2 2025 Financial Results

    Gross Profit Increased by 29% Year-Over-Year, Reaching $61 Million in Q2 with Growth Across All Four Business Segments Achieved 9% Year-Over-Year Growth, Generating Record Q2 Net Revenue of $211 Million, 10% in Constant Currency Beverage Revenue Increase by 36%, International Cannabis by 25%, Wellness Segment by 13% Announces Project 420: A $25 Million Synergy Plan for Tilray Beverage Business Tilray Reaffirms Fiscal Year 2025 Guidance Conference Call to be Held at 8:30 a.m. ET Today NEW YORK and LEAMINGTON, Ontario, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray", "our", "we" or the "Company") (NASDAQ:TLRY, TSX:TLRY), a global lifestyle and consumer packaged goods co

    1/10/25 7:00:50 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Tilray Brands Moves Earnings Date to January 10, 2025, in Observance of the National Day of Mourning

    NEW YORK and LEAMINGTON, Ontario, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (NASDAQ:TLRY, TSX:TLRY), a leading global lifestyle and consumer packaged goods company, today announced that the Company will now release its financial results for the second quarter ended November 30, 2024, before the financial market opens on January 10, 2025. The Company originally scheduled the release of its second quarter financial results before market open on January 9, 2025. This change reflects the observance of the National Day of Mourning in honor of former President Jimmy Carter. Live Conference Call and Audio Webcast Tilray will host a live conference call, w

    1/2/25 5:47:32 PM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Tilray Brands, Inc. to Announce Second Quarter Fiscal Year 2025 Financial Results on January 9, 2025

    NEW YORK and LEAMINGTON, Ontario, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (NASDAQ:TLRY, TSX:TLRY), a leading global lifestyle and consumer packaged goods company, today announced that the Company will release its financial results for the second quarter ended November 30, 2024 before the financial market opens on January 9, 2025. Live Conference Call and Audio Webcast Tilray will host a live conference call, which will be webcast, to discuss these results at 8:30 a.m. Eastern Time. The webcast can be accessed on the Investors section of Tilray's website at www.Tilray.com. About Tilray Brands Tilray Brands, Inc. ("Tilray") (NASDAQ:TLRY, TSX:TLRY

    12/19/24 7:00:00 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Tilray Brands Reports Q1 2025 Financial Results

    Tilray Achieves 13% Year-Over-Year Growth, Generating Record Q1 Net Revenue of $200 Million Q1 Gross Margin Increases Over 500 Basis Points, Representing 20% Year-Over-Year Growth Tilray Beverages Achieves 132% Net Revenue Growth, Tilray Alternative Beverages Launched in October to Fuel Key U.S. Markets with Hemp-Derived Delta-9 THC Products German Medical Cannabis Flower Revenue Increases by 50% Following Legalization Conference Call to be Held at 8:30 a.m. ET Today NEW YORK and LEAMINGTON, Ontario, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray", "our", "we" or the "Company") (NASDAQ:TLRY, TSX:TLRY), a leading global lifestyle and consumer packaged goods company, tod

    10/10/24 7:00:00 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Tilray Brands, Inc. to Announce First Quarter Fiscal Year 2025 Financial Results on October 10, 2024

    NEW YORK and LEAMINGTON, Ontario, Sept. 30, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (NASDAQ:TLRY, TSX:TLRY), a leading global lifestyle and consumer packaged goods company, today announced that the Company will release its financial results for the first quarter which ended August 31, 2024 before the financial market opens on October 10, 2024. Live Conference Call and Audio Webcast Tilray will host a live conference call, which will be webcast, to discuss these results at 8:30 am Eastern Time. The webcast can be accessed on the Investors section of Tilray's website at www.Tilray.com. Investor Q&A Tilray Brands stockholders can submit and upvote question

    9/30/24 3:39:10 PM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Tilray Brands, Inc. Reports Q3 Fiscal 2024 Financial Results

    Achieved Net Revenue of $188 Million, ~ 30% Net Revenue Growth Over the Prior Year Quarter Beverage-Alcohol Net Revenue Increases 165% Over the Prior Year Quarter, 5th Largest Craft Beer Brewer in the U.S.1 with 4.5% Craft Beer Market Share Global Cannabis Net Revenue Increases 33% with International Cannabis Growth of 44% Over the Prior Year Quarter, #1 Market Share in Canada and #1 Market Share in Germany U.S. Cannabis Strategy in Place to Strike with Potential Drug Policy Reform Conference Call to be Held at 8:30 a.m. ET Today NEW YORK and LEAMINGTON, Ontario, April 09, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray", "our", "we" or the "Company") (NASDAQ:TLRY, TSX:TLRY), a

    4/9/24 7:00:00 AM ET
    $BUD
    $TLRY
    Beverages (Production/Distribution)
    Consumer Staples
    Medicinal Chemicals and Botanical Products
    Health Care

    Tilray Brands Inc. Leadership Updates

    Live Leadership Updates

    View All

    Terrapin Beer Co. Celebrates 20 Years of Iconic Wake-n-Bake Beer with Exciting Wake-n-Bake Off Event in Athens, GA

    ATHENS, Ga., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Terrapin Beer Co., a Tilray Beverages craft beer brand under Tilray Brands, Inc. (NASDAQ:TLRY, TSX:TLRY), is excited to announce the 20th anniversary of its Wake-n-Bake Coffee Oatmeal Imperial Stout seasonal beer and the annual Wake-n-Bake Off event on Sunday, January 26th, 2025, at the Terrapin taproom in Athens, GA. In celebration of its 20th anniversary, guests will have the chance to observe local restaurants competing to craft the finest dish featuring Terrapin's renowned Wake-n-Bake Beer. This event highlights culinary innovation and fosters community engagement through an array of sweet and savory tastings that showcase the rich flavor

    1/23/25 7:00:00 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Blue Point Brewing Launches Big Mo Brew to Raise Funds and Awareness for Men's Health During Movember

    PATCHOGUE, N.Y., Oct. 22, 2024 (GLOBE NEWSWIRE) -- Blue Point Brewing Company, Long Island's original craft brewery and subsidiary of Tilray Brands, (NASDAQ:TLRY, TSX:TLRY), is proud to announce the continuation of its men's health awareness campaign in support of Movember. The month shines a light on key men's health issues—mental health, prostate cancer, and testicular cancer—encouraging open conversations and proactive engagement. To honor the initiative, Blue Point Brewing announced the special release of its classic double IPA, Big Mo, available at our brewery and retailers in Long Island, New York. This hazy double IPA, featuring prominent mosaic hops and an ABV of 8.0%, proud

    10/22/24 7:00:00 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Breckenridge Brewery Opens New Location in Fort Collins, Colorado

    FORT COLLINS, Colo., Aug. 05, 2024 (GLOBE NEWSWIRE) -- Breckenridge Brewery, a Colorado-based craft brewer with over 30 years of experience brewing approachable, well-balanced beers, announces the opening of its new brewery location in Fort Collins. With doors opening in early August 2024, the new 10,000-square-foot Breckenridge Brewery offers a full restaurant experience and a new vibrant atmosphere in the heart of Fort Collins for all to enjoy. The new location will be a full-service restaurant, upholding the Breckenridge Brewery legacy while ushering in new opportunities for innovation and community collaboration. With a menu boasting a diverse range of culinary delights designed to co

    8/5/24 7:00:00 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Twist Your Tastebuds Three Ways: Good Supply Cannabis Brand Launches 'Twisted' All-In-One Vapes

    TORONTO, May 30, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (NASDAQ:TLRY, TSX:TLRY), a leading global lifestyle and consumer packaged goods company, today announced the highly anticipated Good Supply® ‘Twisted' All-In-One ("AIO") Vapes hitting the market, offering a revolutionary way to experience its delicious vape flavours. With the ability to switch between complimentary flavours or combining them for a "twist" – creating a unique third flavour experience of the two flavours enjoyed together, Good Supply has a jam packed vape with a series of unique flavour possibilities all-in-one, ready to go for consumers looking for variety that packs a punch. With the new Twisted All-in-One vape

    5/30/24 7:00:00 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Redhook Brewery Announces New "Big Juicy Ballard" IPA and Revives IPA Daze Festival at the Brewlab on 4/20 Weekend

    SEATTLE, April 03, 2024 (GLOBE NEWSWIRE) -- Redhook Brewery, makers of pure Pacific Northwest ale, and a subsidiary of Tilray Brands, Inc. (NASDAQ:TLRY, TSX:TLRY), is introducing the brewery's newest offering: Big Juicy Ballard IPA, a higher ABV, high-octane juice bomb bursting with tropical hops and a lingering sweet finish, hitting shelves this April. Redhook's Big Ballard family pays homage to its original stomping grounds in the Ballard District where Redhook was born in 1981 and builds on the resounding success of our beloved Big Ballard series—featuring the Original, Hazy, and Tropical variations. We proudly introduce the newest member: Big Juicy Ballard. With an impressive ABV of 9

    4/3/24 8:00:00 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    MedMen Announces Ana Bowman as Permanent CFO

    MedMen Enterprises Inc. ("MedMen" or the "Company") (CSE:MMEN) (OTCQX:MMNFF), a premier cannabis retailer with operations across the United States, today announced the appointment of Ana Bowman as Chief Financial Officer, effective February 22, 2022. Bowman succeeds outgoing interim CFO Reece Fulgham, who will be returning to consulting firm SierraConstellation Partners. Bowman brings years of cannabis industry expertise, having served as Vice President of Financial Reporting and FP&A of Tilray Brands (NASDAQ:TLRY, TSX:TLRY), a leading global cannabis lifestyle and consumer packaged goods company. Prior to joining Tilray, Bowman served as Corporate Controller of several publicly-traded U.S

    2/18/22 5:39:00 PM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Tilray Strengthens Leadership Position in Canada

    Blair MacNeil, Former Bacardi General Manager, Joins Tilray to Lead the Company's Canadian Growth Strategy Tilray, Inc. ("Tilray" or the "Company") (NASDAQ:TLRY, TSX:TLRY) announces the expansion of its leadership team with the appointment of Blair MacNeil as President, Tilray Canada. In his new role, Blair will drive Tilray's next stage of growth in Canada and oversee sales, marketing, and operations across medical and adult-use cannabis businesses. Blair will report to Jim Meiers, who has been appointed to Chief Operations Officer, Tilray, Inc. Irwin D. Simon, Chairman and Chief Executive Officer, stated, "Blair MacNeil has a proven track record in driving accelerated growth for indust

    10/19/21 7:30:00 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Hollister Biosciences Inc. Announces Appointment of Two New Board Members; Kevin Harrington, an original "Shark" from the NBC hit TV series "Shark Tank" and Jakob Ripshtein, the former CFO of Diageo North America and President of Aphria

    VANCOUVER, BC, Aug. 31, 2021 /PRNewswire/ - Hollister Biosciences Inc. (CSE:HOLL) (OTC:HSTRF) (FRANKFURT: HOB) (the "Company", "Hollister Cannabis Co." or "Hollister") is pleased to announce the appointment of two new members to its Board of Directors: Mr. Kevin Harrington and Mr. Jakob Ripshtein. Mr. Kevin Harrington is a veteran CEO, bestselling author and platform-building entrepreneur known to millions as one of the original "sharks" on the 4x Emmy-winning ABC series Shark Tank. His many landmark achievements include inventing the infomercial, pioneering the As Seen on TV brand, co-founding the Electronic Retailers Association (ERA), serving as a co-founding board member of the Entrepr

    8/31/21 8:00:00 AM ET
    $CELH
    $TLRY
    Beverages (Production/Distribution)
    Consumer Staples
    Medicinal Chemicals and Botanical Products
    Health Care

    High Tide Announces Addition to the Horizons Marijuana Life Sciences Index ETF (TSX: HMMJ) and Results of Annual General Meeting

    High Tide Inc. ("High Tide" or the "Company") (TSXV:HITI) (NASDAQ:HITI) (FRA: 2LYA), a retail-focused cannabis corporation enhanced by the manufacturing and distribution of consumption accessories, today announced that as per the recently disclosed listing of holdings available on its website, the Company's shares have now been included in Horizons Marijuana Life Sciences Index ETF (TSX:HMMJ). "We are very pleased to have our shares included in the Horizons Marijuana Life Sciences Index ETF," said Raj Grover, President and Chief Executive Officer of High Tide. "This is yet more recognition of High Tide's continued execution which has now resulted in another high profile institution acquiri

    7/30/21 6:05:00 AM ET
    $TLRY
    $HITI
    $ACB
    Medicinal Chemicals and Botanical Products
    Health Care
    Other Specialty Stores
    Consumer Discretionary

    High Tide Announces Addition to the Horizons Marijuana Life Sciences Index ETF (TSX: HMMJ ) and Results of Annual General Meeting

    CALGARY, AB, July 30, 2021 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (TSXV:HITI) (NASDAQ:HITI) (FRA: 2LYA), a retail-focused cannabis corporation enhanced by the manufacturing and distribution of consumption accessories, today announced that as per the recently disclosed listing of holdings available on its website, the Company's shares have now been included in Horizons Marijuana Life Sciences Index ETF (TSX:HMMJ). "We are very pleased to have our shares included in the Horizons Marijuana Life Sciences Index ETF," said Raj Grover, President and Chief Execu

    7/30/21 6:00:00 AM ET
    $TLRY
    $ACB
    $HITI
    Medicinal Chemicals and Botanical Products
    Health Care
    Other Specialty Stores
    Consumer Discretionary

    Tilray Brands Inc. Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Tilray Brands Inc. (Amendment)

    SC 13G/A - Tilray Brands, Inc. (0001731348) (Subject)

    2/13/23 1:34:44 PM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form SC 13G filed by Tilray Brands Inc.

    SC 13G - Tilray Brands, Inc. (0001731348) (Subject)

    2/10/23 4:41:36 PM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form SC 13D filed by Tilray Brands Inc.

    SC 13D - Tilray Brands, Inc. (0001731348) (Filed by)

    7/22/22 4:30:22 PM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form SC 13D filed by Tilray, Inc.

    SC 13D - Tilray, Inc. (0001731348) (Filed by)

    12/17/21 4:40:18 PM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form SC 13D/A filed by Tilray, Inc. (Amendment)

    SC 13D/A - Tilray, Inc. (0001731348) (Subject)

    5/25/21 5:03:22 PM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form SC 13D/A filed

    SC 13D/A - Tilray, Inc. (0001731348) (Subject)

    2/16/21 4:16:09 PM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form SC 13D/A filed

    SC 13D/A - Tilray, Inc. (0001731348) (Subject)

    2/16/21 4:05:42 PM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form SC 13D/A filed

    SC 13D/A - Tilray, Inc. (0001731348) (Subject)

    2/16/21 4:02:05 PM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form SC 13G/A filed

    SC 13G/A - Tilray, Inc. (0001731348) (Subject)

    2/16/21 11:12:08 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form SC 13G/A filed

    SC 13G/A - Tilray, Inc. (0001731348) (Subject)

    2/16/21 10:08:34 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care